Drugs / MenACWY polysaccharide vaccine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00310817 Comparator | Mar 2005 → May 2006 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00262041 Comparator | Oct 2004 → Mar 2006 | meningococcemia | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MenACWY polysaccharide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00310817 ↗ |
| Known as | MenACWY-PS | “compared with a plain polysaccharide vaccine (MenACWY-PS)” PMID 23114372 ↗ Apr 2013 |
| Modality | Vaccine | “polysaccharide vaccine” NCT00262041 ↗ |